SFBC maintained by Jefferies at hold

SFBC International Inc. was maintained by Jefferies & Co., Inc. analyst David Windley at a hold rating after the company announced the departure of its two top executives, Lisa Krinsky and Arnold Hantman. Jeff McMullen, co-cofounder and the head of PharmaNet, is the new chief executive. Installing this seasoned industry executive at the helm should be viewed by investors as positive, Jefferies said. Guidance remains unchanged. Shares of the Miami drug development services company were up $2.88, or 17.99%, at $18.89 on volume of 6,091,822 shares versus the three-month running average of 2,128,770 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.